Product Introduction

The fluorecare® f-PSA Test Kit (Free Prostate Specific Antigen) developed by Microprofit is a quantitative immunofluorescence assay (FIA) designed for the accurate detection of free PSA levels in human serum and plasma. As part of the fluorecare® POCT diagnostic platform, this test kit enables rapid and reliable quantitative analysis, supporting efficient clinical decision-making in laboratories, hospitals, and point-of-care testing environments.

Detection Principle

The fluorecare® f-PSA test kit utilizes fluorescence immunochromatographic assay technology. Free PSA in the sample binds with fluorescent-labeled antibodies to form antigen-antibody complexes, which are captured on the test line. The fluorescence signal is detected and analyzed by the fluorecare® immunofluorescence analyzer, enabling accurate and quantitative measurement of free PSA concentration.

Clinical Applications

Improving the specificity of prostate cancer screening

Calculation of the f-PSA/t-PSA ratio to differentiate cancer from BPH

Reducing unnecessary prostate biopsies in the diagnostic grey zone

Auxiliary risk assessment of prostate disorders

Clinical laboratory and decentralized POCT testing

Frequently Asked Questions

What is the fluorecare® f-PSA test kit used for?

The fluorecare® f-PSA test kit is used for quantitative detection of free prostate specific antigen, mainly combined with total PSA to refine prostate cancer risk assessment.

How fast is the fluorecare® f-PSA test?

The test provides accurate results within 15 minutes using the fluorecare® immunofluorescence analyzer.

What samples can be used for this test?

Serum and plasma samples are suitable for testing with the fluorecare® f-PSA test kit.

Is the fluorecare® f-PSA test suitable for POCT use?

Yes, it is specifically designed for point-of-care testing environments.

Compatible Analyzer

The fluorecare® f-PSA test kit is specifically designed to work with the fluorecare® immunofluorescence analyzer, providing fast, accurate, and quantitative results. This integrated POCT solution ensures efficient workflow and reliable performance for laboratories, clinics, and decentralized healthcare settings.

Quantitative detection based on immunofluorescence assay (FIA)
Rapid results within 15 minutes
High sensitivity and specificity
Seamless integration with fluorecare® POCT platform
Stable performance with internal calibration
User-friendly operation with minimal training required
Suitable for laboratory and point-of-care testing scenarios